R Bassan, E Pogliani, T Lerede, P Fabris, G Rossi, S Morandi, P Casula, G Lambertenghi-Deliliers, M Vespignani, T Izzi, P Coser, G Corneo and T Barbui (1999) “Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study”, Haematologica. Pavia, Italy, 84(12), pp. 1088-1093. doi: 10.3324/%x.